AVONEX(R), The Most Prescribed Multiple Sclerosis Therapy Worldwide, May Now Be Given with Smaller Needle
Tuesday June 20, 9:32 am ET
Additional Supplemental Application for Convenient Needle Locking System and Change In Room Temperature Storage Filed with FDA
CAMBRIDGE, Mass.--(BUSINESS WIRE)--June 20, 2006--AVONEX® (Interferon beta 1a), the most prescribed multiple sclerosis (MS) therapy worldwide may now be administered with a needle that is 20 percent shorter and thinner than the currently approved needle. People living ...